Ying Ji Buechler

age ~62

from Carlsbad, CA

Also known as:
  • Ying J Buechler
  • Ying J Cuechler
  • Ying Ji
  • Buechler Ying Ji
  • Ji Buechler Ying
Phone and address:
1343 Cassins St, Carlsbad, CA 92008
7608049133

Ying Buechler Phones & Addresses

  • 1343 Cassins St, Carlsbad, CA 92008 • 7608049133
  • San Diego, CA
  • La Jolla, CA
  • Oceanside, CA
  • 1343 Cassins St, Carlsbad, CA 92011

Work

  • Company:
    Ambrx
    Dec 2003
  • Position:
    Director, product development and characterization

Education

  • Degree:
    Ph.D.
  • School / High School:
    University of California, San Diego
    1986 to 1992
  • Specialities:
    Biochemistry

Skills

Protein Chemistry • Protein Purification • Biotechnology • Purification • Biochemistry • Analytical Chemistry • Technology Transfer • Molecular Biology • Formulation • R&D • Recombinant Dna Technology • Clinical Development • Process Simulation • Science

Industries

Biotechnology

Resumes

Ying Buechler Photo 1

Vice President, Development

view source
Location:
San Diego, CA
Industry:
Biotechnology
Work:
Ambrx since Dec 2003
Director, Product Development and Characterization
Education:
University of California, San Diego 1986 - 1992
Ph.D., Biochemistry
Skills:
Protein Chemistry
Protein Purification
Biotechnology
Purification
Biochemistry
Analytical Chemistry
Technology Transfer
Molecular Biology
Formulation
R&D
Recombinant Dna Technology
Clinical Development
Process Simulation
Science

Us Patents

  • Methods For Expression And Purification Of Pegylated Recombinant Human Growth Hormone Containing A Non-Naturally Encoded Keto Amino Acid

    view source
  • US Patent:
    7947473, May 24, 2011
  • Filed:
    Jan 31, 2008
  • Appl. No.:
    11/874100
  • Inventors:
    Ying Buechler - Carlsbad CA, US
    Ricky Lieu - San Diego CA, US
    Michael Ong - San Diego CA, US
    Stuart Bussell - Carlsbad CA, US
    Nick Knudsen - San Diego CA, US
    Ho Sung Cho - San Diego CA, US
  • Assignee:
    AMBRX, Inc. - La Jolla CA
  • International Classification:
    C12N 15/09
    A61K 38/27
    C07K 14/00
  • US Classification:
    435 694, 424123, 424124, 514 114, 530399, 530416
  • Abstract:
    The present invention relates generally to the production, purification, and isolation of human growth hormone (hGH). More particularly, the invention relates to the production, purification, and isolation of substantially purified hGH comprising non-naturally encoded amino acids and hGH from recombinant host cells or culture medium including, for example, yeast, insect, mammalian and bacterial host cells. The process of the present invention is also useful for purification of hGH linked to polymers or other molecules.
  • Methods For Expression And Purification Of Recombinant Human Growth Hormone Mutants

    view source
  • US Patent:
    7959926, Jun 14, 2011
  • Filed:
    Oct 17, 2007
  • Appl. No.:
    11/874068
  • Inventors:
    Ying Buechler - Carlsbad CA, US
    Ricky Lieu - San Diego CA, US
    Michael Ong - San Diego CA, US
    Stuart Bussell - Carlsbad CA, US
    Nick Knudsen - San Diego CA, US
    Ho Sung Cho - San Diego CA, US
  • Assignee:
    Ambrx, Inc. - La Jolla CA
  • International Classification:
    A61K 39/00
    A61K 38/02
    A61K 38/27
    C12P 21/00
    C07K 1/16
    C07H 21/00
  • US Classification:
    4242001, 4241981, 424124, 536 2351, 514 114, 435 76, 435 691, 530417
  • Abstract:
    The present invention relates generally to the production, purification, and isolation of human growth hormone (hGH). More particularly, the invention relates to the production, purification, and isolation of substantially purified hGH comprising non-naturally encoded amino acids and hGH from recombinant host cells or culture medium including, for example, yeast, insect, mammalian and bacterial host cells. The process of the present invention is also useful for purification of hGH linked to polymers or other molecules.
  • Process Of Producing Non-Naturally Encoded Amino Acid Containing High Conjugated To A Water Soluble Polymer

    view source
  • US Patent:
    8080391, Dec 20, 2011
  • Filed:
    Dec 21, 2005
  • Appl. No.:
    11/315752
  • Inventors:
    Ying Buechler - Carlsbad CA, US
    Ricky Lieu - San Diego CA, US
    Michael Ong - San Diego CA, US
    Stuart Bussell - Carlsbad CA, US
    Nick Knudsen - San Diego CA, US
    Ho Sung Cho - San Diego CA, US
  • Assignee:
    AMBRX, Inc. - La Jolla CA
  • International Classification:
    C12N 15/09
    A61K 38/27
    C07K 14/00
  • US Classification:
    435 694, 435123, 514 114, 530399, 530416
  • Abstract:
    The present invention relates generally to the production, purification, and isolation of human growth hormone (hGH). More particularly, the invention relates to the production, purification, and isolation of substantially purified hGH from recombinant host cells or culture medium including, for example, yeast, insect, mammalian and bacterial host cells. The process of the present invention is also useful for purification of hGH linked to polymers or other molecules.
  • Formulations Of Human Growth Hormone Comprising A Non-Naturally Encoded Amino Acid

    view source
  • US Patent:
    8163695, Apr 24, 2012
  • Filed:
    Oct 25, 2007
  • Appl. No.:
    11/924154
  • Inventors:
    Anna-Maria A. Hays - San Diego CA, US
    Ying Buechler - Carlsbad CA, US
    David C. Litzinger - Poway CA, US
  • Assignee:
    Ambrx - La Jolla CA
  • International Classification:
    A61K 38/27
    C07K 14/61
    C07K 1/107
  • US Classification:
    514 114, 4241981, 530350, 530399, 530402
  • Abstract:
    Formulations of modified human growth hormone polypeptides are provided.
  • Methods For Expression And Purification Of Recombinant Human Growth Hormone

    view source
  • US Patent:
    8178108, May 15, 2012
  • Filed:
    Oct 17, 2007
  • Appl. No.:
    11/874086
  • Inventors:
    Ying Buechler - Carlsbad CA, US
    Ricky Lieu - San Diego CA, US
    Michael Ong - San Diego CA, US
    Stuart Bussell - Carlsbad CA, US
    Nick Knudsen - San Diego CA, US
    Ho Sung Cho - San Diego CA, US
  • Assignee:
    Ambrx, Inc. - La Jolla CA
  • International Classification:
    A61K 38/27
    A61K 38/18
    A61K 39/00
    C07K 1/14
    C07K 1/16
    C07K 1/18
    C07H 21/04
  • US Classification:
    4241981, 424123, 424124, 4242001, 514 32, 514 114, 530399, 530412, 530416, 530417, 435 694, 435 691, 536 2351
  • Abstract:
    The present invention relates generally to the production, purification, and isolation of human growth hormone (hGH). More particularly, the invention relates to the production, purification, and isolation of substantially purified hGH comprising non-naturally encoded amino acids and hGH from recombinant host cells or culture medium including, for example, yeast, insect, mammalian and bacterial host cells. The process of the present invention is also useful for purification of hGH linked to polymers or other molecules.
  • Modified Human Growth Hormone Formulations With An Increased Serum Half-Life

    view source
  • US Patent:
    8178494, May 15, 2012
  • Filed:
    Oct 25, 2007
  • Appl. No.:
    11/924242
  • Inventors:
    Anna-Maria Hays - La Jolla CA, US
    Ying Buechler - Carlsbad CA, US
    David C. Litzinger - Poway CA, US
  • Assignee:
    AMBRX, Inc. - La Jolla CA
  • International Classification:
    A61K 38/27
    A61K 39/00
    C07K 14/61
    C07K 14/00
  • US Classification:
    514 114, 530399, 530402, 4241981
  • Abstract:
    Formulations of modified growth hormone polypeptides are provided, including human growth hormone polypeptides with one or more non-naturally encoded amino acids with an increased half-life.
  • Pegylated Interferon Alpha-1B

    view source
  • US Patent:
    20060029573, Feb 9, 2006
  • Filed:
    Jun 30, 2005
  • Appl. No.:
    11/172409
  • Inventors:
    Chun Shen - San Diego CA, US
    Ying Buechler - Carlsbad CA, US
    Xiaochun Chen - Carlsbad CA, US
    Dawn Wen - San Diego CA, US
    Yixin Wang - Shenzhen, CN
    Shehui He - Shenzhen, CN
    Qianlan Wang - Shenzhen, CN
  • International Classification:
    A61K 38/21
    C07K 14/56
  • US Classification:
    424085700, 530351000
  • Abstract:
    The invention provides PEG-IFN α-1b conjugates, where a PEG moiety is covalently bound to Cysof human IFN α-1b conjugates. A pharmaceutical composition and a method for treating inflammatory diseases, infections, and cancer are also provided. The invention further relates to a method for the modification of interferons by conjugation of a PEG moiety to free cysteine residues in interferon molecules.
  • Formulations Of Human Growth Hormone Comprising A Non-Naturally Encoded Amino Acid

    view source
  • US Patent:
    20060135427, Jun 22, 2006
  • Filed:
    Dec 21, 2005
  • Appl. No.:
    11/316483
  • Inventors:
    Anna-Maria Hays - La Jolla CA, US
    Ying Buechler - Carlsbad CA, US
    David Litzinger - Poway CA, US
  • Assignee:
    Ambrx, Inc. - La Jolla CA
  • International Classification:
    A61K 38/27
  • US Classification:
    514012000
  • Abstract:
    Formulations of modified human growth hormone polypeptides are provided.

Get Report for Ying Ji Buechler from Carlsbad, CA, age ~62
Control profile